Is there a role for sulfasalazine in the treatment of alopecia areata?

Journal of the American Academy of Dermatology

Volumn 57, Issue 4, 2007, Pages 703-706

  Bakar, Özgür ^a   Gurbuz, Oya ^b  

^a Acibadem Kozyatagi Hospital   (Turkey)

^b MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DITHRANOL; METHYLPREDNISOLONE; MINOXIDIL; SALAZOSULFAPYRIDINE; STEROID;

ADOLESCENT; ADULT; ALOPECIA AREATA; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DRUG EFFICACY; FEMALE; FOLLOW UP; HAIR GROWTH; HUMAN; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; ADULT; ALOPECIA AREATA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HUMANS; MIDDLE AGED; SULFASALAZINE;

EID: 34548527137     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.10.980     Document Type: Review

References (28)

1. Meidan V.M., and Touitou E. Treatments or androgenetic alopecia and alopecia areata current options and future prospects. Drugs 61 (2001) 53-69
2. Wolf R., Matz H., Zalish M., Pollack A., and Orion E. Prostaglandin analogs for hair growth: great expectations. Dermatol Online J 9 (2003) 7-15
3. Tosti A., Piraccini B.M., Pazzaglia M., and Vincenzi C. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. J Am Acad Dermatol 49 (2003) 96-98
4. Abell E., and Munro D.D. Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector. Br J Dermatol 88 (1973) 55-59
5. Freidli A., Labarthe M.P., Engelhard E., Feldmann R., Salomon D., and Saurat J.H. Pulse methylprednisolone therapy for severe alopecia areata: an open prospective study of 45 patients. J Am Acad Dermatol 39 (1998) 597-602
6. Shapiro J., Lui H., Tron V., and Ho V. Systemic cyclosporine and low-dose prednisone in the treatment of chronic severe alopecia areata: a clinical and immunopathologic evaluation. J Am Acad Dermatol 36 (1997) 114-117
7. Parodi A., and Rebora A. Topical cyclosporine in the treatment of alopecia areata. Arch Dermatol 123 (1987) 165-166
8. Taylor C.R., and Hawk J.L. PUVA treatment of alopecia areata, partialis, totalis and universalis: audit of 10 years' experience at St John's Institute of Dermatology. Br J Dermatol 133 (1995) 914-918
9. Benardo O., Tang L., Lui H., and Shapiro J. Topical nitrogen mustard in the treatment of alopecia areata; a bilateral comparison study. J Am Acad Dermatol 49 (2003) 291-300
10. Zakaria W., Passeron T., Ostovari N., Lacour J.P., and Ortonne J.P. 308-nm excimer laser therapy in alopecia areata. J Am Acad Dermatol 51 (2004) 837-838
11. MacDonald Hull S.P., Wood M.L., Hutchinson P.E., Sladden M., and Messenger A.G. British Association of Dermatologists. Guidelines for the management of alopecia areata. Br J Dermatol 149 (2003) 692-699
12. Rockshar C.K., Shupack J.L., Vafai J.J., and Washenik K. Efficacy of topical sensitizers in the treatment of alopecia areata. J Am Acad Dermatol 39 (1998) 751-761
13. Cotellesa C., Peris K., Caraciollo E., Mordenti C., and Chimenti S. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata. J Am Acad Dermatol 44 (2001) 73-76
14. Pardasani A.G., Turner E., and McMichael A.J. Squaric acid dibutylester: indications for use and efficacy in alopecia areata. Arch Dermatol 137 (2001) 970-972
15. Price V.H., Willey A., and Chen B.K. Topical tacrolimus in alopecia areata. J Am Acad Dermatol 52 (2005) 138-139
16. McMichael A.J. The new biologics in psoriasis: possible treatments for alopecia areata. J Investig Dermatol Symp Proc 8 (2003) 217-218
17. Sasmaz S., and Arican O. Comparison of azelaic acid and anthralin for the therapy of patchy alopecia areata. Am J Clin Dermatol 6 (2005) 403-406
18. Skinner R.B. Imiquimod. Dermatol Clin 21 (2003) 291-300
19. Smedegard G., and Bjork J. Sulphasalazine: mechanism of action in rheumatoid arthritis. Br Soc Rheumatol 34 Suppl 2 (1995) 7-15
20. Donovan S., Hawley S., MacCarthy J., and Scott D.L. Tolerability of enteric-coated sulfasalazine in rheumatoid arthritis: results of a co-operating clinics study. Br J Rheumatol 29 (1990) 201-204
21. Chen C.C., Lin Y.T., Yang Y.H., and Chiang B.L. Sulfasalazine therapy for juvenile rheumatoid arthritis. J Formos Med Assoc 101 (2002) 110-116
22. Watkinson G. Sulfasalazine: a review of 40 years' experience. Drugs 32 Suppl 1 (1986) 1-11
23. Ellis C.N., Brown M.F., and Voorhees J.J. Sulfasalazine for alopecia areata. J Am Acad Dermatol 46 (2002) 541-544
24. Olsen E., Hordinsky M., McDonald-Hull S., Price V., Roberts J., Shapiro J., et al. Alopecia areata investigational assessment guidelines. J Am Acad Dermatol 40 (1999) 242-246
25. Madani S., and Shapiro J. Alopecia areata update. J Am Acad Dermatol 42 (2000) 549-566
26. Cunliffe R.N., and Scott B.B. Review article: monitoring for drug side-effects in inflammatory bowel disease. Aliment Pharmacol Ther 16 (2002) 647-662
27. Rains C.P., Noble S., and Faulds D. Sulfasalazine: a review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis. Drugs 50 (1995) 137-156 Erratum in: Drugs 1995;50:625
28. Gupta A.K., Ellis C.N., Cooper K., Nickoloff B.C., Ho V.C., Chan L.S., et al. Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis. J Am Acad Dermatol 22 (1990) 242-250